Post-COVID and with a national-level strategy in place to bolster its traditional strengths as well as spearhead entry into new sectors, Hong Kong has reason for optimism once again. One of two special administrative regions (SARs) in southern China with separate laws and…
It is undeniable that Belgium holds a strong position as a vibrant life sciences hub at the heart of Europe. Although the country itself represents only a mid-sized marketplace, Belgium boasts a robust environment that fosters multinational drug makers as well as home-grown…
Thanks to a more stable macroeconomic and political footing than at any time in the past 15 years, Greeks once more have cause for cautious optimism about their country’s direction of travel. Many of the half a million educated young people who left the country in search…
This exclusive new report, bringing together stakeholders from across the Latin American healthcare and life sciences ecosystem, shines a light on a continent, and an industry, poised for increased global relevance in the coming years. While economic and political…
PharmaBoardroom’s latest report, InFigures: Asia Pacific 2023 features up-to-date datasets from the region’s leading pharma markets and regional innovation hubs. Covering everything from population health to market growth, company rankings, innovation footprints, IPOs,…
Currently in the midst of a generational transformation of its healthcare system, Egypt has more to recommend it than ever to the global life sciences investment community. Not only is the country attempting to bring its entire 100+ million population under some form of…
With the tremendous healthcare momentum that is already underway in the Gulf Cooperation Council (GCC) countries, driven by economic diversification and transformation, the future of healthcare in the region looks bright. Government initiatives such as Saudi Arabia’s…
At a crucial moment ahead of a snap general election on 25 September 2022, this new report looks back at the progress that Italy’s healthcare and life sciences sector has made in recent years and assesses its future prospects. While the country’s political winds are…
Having foregrounded its life sciences credentials with the establishment of manufacturing and clinical trials hubs, Spain is hoping to secure its position as a globally relevant industry player. The Iberian nation can boast an advanced healthcare system – which has…
PharmaBoardroom’s latest report, InFigures: Middle East & Africa (MENA) 2022 features up-to-date datasets from the region’s leading pharma markets and regional production hubs. MENA may be the smallest pharmaceutical market in the world, accounting for just 2 percent…
PharmaBoardroom’s latest report, InFigures: European Pharma Hotspots 2022 features up-to-date datasets from six major European pharma hubs. Europe is the world’s second biggest pharma market region and boasts the headquarters of some of the world’s largest pharma…
PharmaBoardroom’s latest report, InFigures: Latin America 2022 features up-to-date datasets from the region’s leading pharma markets and regional production hubs. A regional market of USD 98 billion looks set to be the fastest growing in the world over the next few…